Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Bullish Bitcoin Predictions Continue to Rise Despite Growing FUD and Bear Market Expectations

Bullish Bitcoin Predictions Continue to Rise Despite Growing FUD and Bear Market Expectations

CryptonewslandCryptonewsland2025/11/23 12:06
By:by Nicole D'souza
  • Bullish Bitcoin predictions continue to rise. 
  • Despite growing FUD and bear market expectations, new bull targets are expected. 
  • Some analysts expect a final BTC price pump in high 6-digit prices.

Bitcoin (BTC), the pioneer crypto asset, is preparing to close the week in the $86,000 price range. Analysts come together to predict where the price of BTC will go as the month nears its final weeks. At the moment, bullish Bitcoin predictions continue to rise despite growing FUD and bear market expectations. Some of these predictions are going as high as $150,000 – $200,000 for BTC. 

Bullish Bitcoin Predictions Continue to Rise 

According to CoinMarketCap analytics, the price of Bitcoin (BTC) is currently trading at the $86,000 price range. Showing that the asset is almost 2% higher than it was trading 24 hours ago. Is this a sign of BTC recovering, or is this just a weekend pump, like the pioneer crypto asset pulled the last few weekends prior to this week. At the moment, sentiments for BTC to hit higher ATH prices this year are very low. 

While most analysts are delving into a stage of complete bear market expectations, others are expecting an even worse state of financial crisis in the coming months ahead. Meanwhile, some believe 2026 will usher in a new bullish cycle, but only by the end of the year. This means chances to accumulate bullish crypto assets will continue to rise over the next few months. But, crypto assets need to bottom before the accumulation phase can begin . 

$Bitcoin just confirming the incoming bullrun for $150k – $200k

But remember guys If $BTC can break down $80k then we will see $75k – $70k

Otherwise If #BTC can break up $98k then we will see real bullrun ✅

Retailers already is allout from the market

Again and again all… pic.twitter.com/5G1sO5G2gg

— TOP GAINER TODAY (@RoccobullboTTom) November 22, 2025

As we can see from the post above, this reputed crypto analyst shares a keen observation on the BTC price chart and predicts a sharp rise in crypto prices in the coming months ahead. For now, the post states that there will be an incoming bull run that will take the price of BTC from $150,000 to $200,000. However, he advises watching out for BTC breaking down $80,000 and hit a price level between $70,000 – $75,000.  

Growing FUD and Bear Market Prevail

$BTC bottom has already formed

My plan for next 60-90 days:

82k -> 126k -> 120k -> 160k -> 50k pic.twitter.com/yVAUEt9gj0

— Aralez 🐕 (@0xAralez) November 22, 2025

On the contrary, another analyst believes that the price of BTC will rise a lot sooner than expected. In detail, this post states that the BTC bottom has already formed, this means that the price of BTC will start pumping towards a bullish price surge in the coming days ahead. To highlight, this analyst  reveals that his plan for the next 60-90 days is to watch the price of BTC go from $82,000 to $126,000 to $120,000 to $160,000, and finally to $50,000.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

- SEC approves multiple XRP/DOGE ETFs from 21Shares, Franklin Templeton, and Grayscale, signaling growing institutional acceptance of altcoins. - 21Shares' TOXR ETF gains automatic approval via CME CF XRP-Dollar tracking, with Coinbase and BNY Mellon handling custody/admin functions. - Franklin Templeton's XRP Trust removes restrictive clauses to accelerate listing, offering regulated exposure without custody risks from ledger forks. - Grayscale expands crypto offerings with XRP/DOGE ETFs on NYSE, joining

Bitget-RWA2025/11/23 20:48
XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

- Germany's SolarPlus Forum 2025 emphasized legislative clarity, funding innovation, and cross-sector collaboration to accelerate solar adoption amid evolving energy policies. - Outdated regulations and permitting hurdles were highlighted as barriers, with calls to align Bundestag reforms with market demands like gas surcharge removal by 2026. - Cement industry growth (5.7% CAGR) and green innovations support infrastructure needs, though energy cost volatility and compliance challenges persist. - Internati

Bitget-RWA2025/11/23 20:48
Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

Bitget-RWA2025/11/23 20:30
Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats

- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

Bitget-RWA2025/11/23 20:30
Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats